Clinical Trials Directory

Trials / Completed

CompletedNCT03615339

Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults

The Use of Fermented Whey Concentrate in Healthy Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
University of Aberdeen · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Pilot trial: 6-week single arm intervention. Healthy adults (male and female) consume Molkosan (fermented whey) twice a day (AM \& PM).

Detailed description

Molkosan® is made from fresh organic whey using a special fermentation process involving lactic acid producing bacteria (L+ lactic acid 70g/L). The company, A.Vogel (Roggwil, Switzerland) will provide the product and we will collect biological samples for analysis in a proof of concept study design that will provide preliminary data for future larger studies.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMolkosanTwice daily (AM and PM) 20ml of fermented whey concentrate consumed diluted in 200ml water

Timeline

Start date
2015-03-16
Primary completion
2015-07-07
Completion
2015-07-07
First posted
2018-08-03
Last updated
2018-08-03

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03615339. Inclusion in this directory is not an endorsement.

Pilot Trial Investigating Fermented Whey Supplementation in Healthy Adults (NCT03615339) · Clinical Trials Directory